Sign Up to like & get
recommendations!
0
Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0254466
Abstract: Relaxin/insulin-like family peptide receptor 1 (RXFP1) mediates relaxin’s antifibrotic effects and has reduced expression in the lung and skin of patients with fibrotic interstitial lung disease (fILD) including idiopathic pulmonary fibrosis (IPF) and systemic sclerosis…
read more here.
Keywords:
lung;
activity fibrotic;
rxfp1;
differential activity ... See more keywords